Fullerenol - A new nanopharmaceutic?

Archive of Oncology

Volumn 16, Issue 3-4, 2008, Pages 42-45

  Dordević, Aleksandar ^a   Bogdanović, Gordana ^b  

^a UNIVERSITY OF NOVI SAD   (Serbia)

^b ONCOLOGY INSTITUTE OF VOJVODINA   (Serbia)

Author keywords

Antioxidants; Doxorubicin; Drug toxicity; Fulleren; Protective agents; Radiation protective agents

Indexed keywords

AMIFOSTINE; ANTIOXIDANT; CISPLATIN; DOXORUBICIN; FULLERENE DERIVATIVE; FULLERENOL; HYDROXYL RADICAL; NITROUS OXIDE; PACLITAXEL; RADIOPHARMACEUTICAL AGENT; SCAVENGER; SUPEROXIDE; TECHNETIUM CARBONIL FULLERENOL TC 99M; TECHNETIUM FULLERENOL TC 99M; TIAZOFURIN; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CARDIOTOXICITY; DRUG ACCUMULATION; DRUG DISTRIBUTION; DRUG DOSE COMPARISON; DRUG ELIMINATION; DRUG MECHANISM; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME MECHANISM; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LD 50; NANOPHARMACEUTICS; NONHUMAN; RADIATION INJURY; RADIATION PROTECTION; REVIEW; TISSUE INJURY;

EID: 65649139650     PISSN: 03547310     EISSN: None     Source Type: Journal    
DOI: 10.2298/AOO0604042D     Document Type: Review

References (44)

1. 60-Buckminster fullerene. Nature. 1985;318:162-3.
2. Hirsch A, Brattreich M. Fullerenes, Chemistry and Reaction. New York: Wiley-VCH; 2004.
3. Wilson SR, Schuster DI, Nuber B, Meier MS, Maggini M, Prato M, et al. Organic chemistry of fullerenes. In: Kadish KM, Ruoff RS, editors. Fullerenes: Chemistry, Physics and Technology. New York: Wiley-Interscience; 2000. p. 91-177.
4. Dresselhaus MS, Dresselhaus G, Eklund PC. Science of Fullerenesa and carbon nanotubes. San Diego: Academic Press; 1996.
5. Bosi S, Feruglio L, Da Ros T, Spalluto G, Gregoretti B, Terdoslavich M, et al. Hemolytic effects of water-soluble fullerene derivatives. J Med Chem. 2004;47:6711-5.
6. n-precursors. J Phys Chem Solids. 2001;62:999-1001.
7. Milkawa M, Kato H, Okumura M, Narazaki M, Kanazawa Y, Miwa N, et al. Paramagnetic water-soluble metallofullerenes having the highest relaxivity for MRI contrast agents. Bioconjugate Chem. 2001;12:510-4.
8. Xing G, Zhang J, Zhao Y, Tang J, Zhang B, Gao X, et al. Influences of structural properties on stability of fullerenes. J Phys Chem B. 2004;108:11473-9.
9. Chiang LY, Bhonsle JB, Wang L. Efficient one-flask synthesis of water-soluble (60) fullerenes. Tetrahedron. 1996;52:4963-72.
10. Gohei Y, Kazulaka I, Fumio G. AU patent 2003/296175 Al.
11. 1B in aqueous solution. Faraday Trans. 1998;94:359-63.
12. Jian-Min Z, Wen Y, Ping H, Shi-Zheng Z. Efficient and convenient preparation of water-soluble fullerenol. Chin J Chem. 2004;22:1008-11.
13. 60. J Chem Soc Chem Commun. 1994;463-4.
14. Chaing LY, Wang LY, Swirczevski JW, Soled S, Camerot S. Efficient synthesis of polyhydroxylated fullerene derivatives via hydrolysis of polycyclosulfated precursors. J Org Chem. 1994;59:3960-8.
15. Okulbo K, Matsubayashi K, Tategaki H, Takada H, Oshima T. Facile synthesis of highly water-soluble fullerenes more than half-covered by hydroxyl groups ACS Nano, 2008;2:327-33.
16. 60 fullerol. Adv Funct Mater. 2006;16:120-8.
17. Brant A Robichaund CO, Wiesner M. Fullerol cluster formation in aqueous solutions: Implications for environmental release. J Colloid Interface Science. 2007;314:281-8
18. Anderson R, Barron AR. Reaction of hydroxyfullerene with metal salts: A route to remediation and immobilization. J Am Chem Soc. 2005;127:10458-9.
19. Ičević, Djordjević A. Fullerenol polydentat ligand. Tehnika. 2006;2:7-9 (in Serbian).
20. Kamat JP, Devasagayama TPA, Priyadarshi KI, Monah H. Reactive oxygen species mediated membrane damage induced by fullerene derivatives and its possible biological implications. Toxicology. 2000;30:55-61.
21. Lai HS, Chen WJ, Chaing LY. Free radical scavenging activity of fullerenol on the ischemia-reperfusion intestine in dogs. World J Surg. 2000;24:450-4.
22. 60, fullerenols, as glutamate receptor antagonists and neuroprotective agents, Neurosci Res. 2000; 62:600-7.
23. Mashino T, Nishiskawa D, Takahaski K, Usui N, Yamori T, Seki M, et al. Antibacterial and antiproliferative activity of cationic fullerene derivatives. Bioorg Med Chem. 2003;13:4395-7.
24. Robert JE, Wielgus AR, Boyes WK, Andley J, Chignell CF Photoxicity and cytotoxicity of fullerenol in human lens epithelial cells. Tox App Pharm. 2008;228:49-58.
25. Sayes CM, Fortner JD, Guo W, Lyon D, Boyd AM, Ausman KD, et al. The different cytotoxicity of water soluble fullerenes. Nano Lett. 2004;4:1881-7.
26. Isakovic A, Markovic Z, Todorovic-Markovic B, Nikolic N, Vranjes-Djuric S, Mirkovic M, et al. Distinct cytotoxic mechanisms of pristine versus hydroxylated fullerene, Toxicol Sci. 2006;91:173-83.
27. Pickering KD, Wiesner MR. Fulelrenol-sensitized production of reactive oxygen species in aqueous solution. Environ Sci Technol. 2005;39:1359-65.
28. Yamawaki H, Iwai N, Yamawaki H, Iwai N. Cytotoxicity of water-soluble fullerene in vascular endothelial cells. Am J Physiol Cell Physiol. 2006;290:1495-502.
29. Dugan LL, Gabrielsen JK, Yu SP, Lin TS, Choi DW. Buckminsterfullerenol free radical scavengers reduce excitotoxic and apoptotic death of cultured cortical neurons. Neurobiol Dis. 1996;3:129-35.
30. 60 in PC 12 cells. Life Sci. 2000;66:1525-33.
31. 24, Oxid Commun. 2005;27:806-12.
32. Mirkov S, Djordjevi ́A, Andric N, Andric S, Kostic T, Bogdanovic G, et al. Nitric oxide-scavenging activity of polyhidroxylated fullerenol. Nitric Oxide Biol Chem. 2004;11:201-7.
33. 24 on cytotoxicity induced by antitumor drugs on human breast carcinoma cell lines. Mater Sci Forum. 2005;492:543-8.
34. Foley S, Crowley C, Smaihi M, Bonfils C, Erlanger FB, Seta P, et al. Cellular localization of a water-soluble fullerene derivatives. Biochem Biophys Res Commun. 2002;294:116-9.
35. 22 on doxorubicin-induced cytotoxicity Toxicol in vitro. 2004;18:629-37.
36. 24 effects on antioxidative enzymes activity in irradiated human erythroleukemia cell line. J Radiat Res. 2008; 9:321-7.
37. Ičević I, Bogdanović V, Žikić D, Šolajić S, Bogdanović G, Djordjević: A. The influence of fullerenol on cell number, cell area, and colony forming unit ability in irradiated human eritroleukemic cell line. Hemijska industrija. 2007;61:167-9.
38. Daroczi B, Kari G, McAleer MF, Wolf JC, Rodeck U, Dicker AP. In vivo radioprotection by the fullerene nanoparticle DF-1 as assessed in a zebrafish model. Clin Cancer Res. 2006;12:7086-91.
39. Niva Y, Iwai N. Genotoxicity in cell lines induced by chronic exposure to water-soluble fullerenes using micronucleus test. Environ Health Prev Med. 2006;11:292-7.
40. Trajkovic S, Dobric S, Djordjević A, Dragojevic-Simic V, Milovanovic Z. Radioprotective efficiency of fullerenol in irradiated mice. Materials Sci Forum. 2005;494:549-54.
41. 24 and amifostine in irradiated rats. Colloids Suferfaces. Colloid Surface B. 2007;58:39-43.
42. 24 on doxorubicin induced cardiotoxicity in rats. Mater Sci Forum. 2006; 518:525-9.
43. 24 and amifostine in irradiated rats. Toxicol Lea. 2007;172S:Sl46.
44. Maksin T, Djokic D, Jankovic D, Djordejvic A, Nešković D. Comparison of some physico-chemical parameters and biological behavior of fullerenollabelled within technecium-99m. J Optoelectron Adv Mat. 2007;9:2571-7.